News

Dr. Margaret Chen is conducting the MammaPrint study looking at genetic biomarkers among Chinese women with early stage breast cancer in the US and Hong Kong.

Researchers at NYP/Columbia have recently launched an important trial of immunotherapy plus chemotherapy as neoadjuvant therapy for patients with locally advanced non-small cell lung cancer (NSCLC).

GERD (gastroesophageal reflux disease) now affects nearly 65 million Americans. Also called acid reflux or heartburn, GERD occurs when stomach contents back up into the esophagus. Untreated, it can lead to Barrett’s esophagus, a dangerous precancerous condition. Most people with GERD can be effectively treated using acid-blocking medication, but nearly a third continue to have symptoms.

The Structural Heart and Valve Center at NYP/Columbia has long been a leader in catheter-based treatment—the least invasive therapy—to repair the mitral valve. This valve regulates blood flow between the upper and the lower chambers on the left side of the heart. When it is damaged or defective, blood flows back up into the upper chamber, producing Mitral Regurgitation (MR).

Babies born with heart defects are now more likely to be successfully treated and grow into healthy adults. Yet this has created a new set of challenges: how to care for the first-generation who had childhood surgeries for congenital heart disease.